Pinealon dosing & administration
Neuroprotective tripeptide bioregulator (Glu-Asp-Arg) that penetrates the DNA major groove to epigenetically regulate serotonin synthesis, preserve dendritic spine architecture, and activate endogenous antioxidant defenses against age-related neurodegeneration
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
1-2 mg
Frequency
Once daily
Duration
10-20 day cycle
Community-reported subcutaneous protocol used in practice. No human trials support this route; the injectable dose is community-derived [6].
Timing
Best time to take
Morning administration is generally preferred. Consistency matters more than the specific time of day.
With food?
Take on an empty stomach for optimal absorption.
If stacking
If combining Pinealon with other peptides, space administrations by 15-30 minutes. Consult your healthcare provider before combining with prescription medications.
Adjusting your dose
Increase if
- Current dose is well-tolerated for 2+ weeks
- Desired effects not yet noticeable
- Healthcare provider recommends dose increase
Decrease if
- Side effects become bothersome or persistent
- Desired effects achieved at lower dose
- Healthcare provider recommends reduction
Signs of right dose
- Noticeable improvement in target symptoms
- Good tolerance with minimal side effects
- Consistent positive response between doses
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)
Best sites
Storage
Before reconstitution
Store in refrigerator at 36-46°F (2-8°C). Keep in original packaging to protect from light. Do not freeze.
After reconstitution
Store reconstituted solution in refrigerator at 36-46°F (2-8°C). Use within 30 days. Do not freeze reconstituted solution.
Signs of degradation — discard the vial
Sample daily schedule
Morning (or as directed)
10-20 mg injection
Site: Rotate injection sites
Administer multiple times daily. Maintain consistency for optimal results.
Safety
Is it safe?
Side effects
Commonly reported: Mild drowsiness, Mild headache, Vivid dreams, Mild gastrointestinal discomfort
Less common: Transient mood changes, Changes in sleep patterns
Stop and seek help if
- Severe allergic reaction—difficulty breathing, significant swelling, or anaphylaxis
- Persistent or worsening side effects that don't resolve with dose adjustment
- Your healthcare provider recommends discontinuation
- Pregnancy or planned pregnancy
- Achievement of treatment goals (discuss maintenance protocol with provider)
Pinealon should only be used under the guidance of a qualified healthcare provider. This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, adjusting, or stopping any peptide protocol.
Flagged pairings
- High-dose SSRI or MAOI antidepressants without medical supervision — potential additive serotonergic effects from Pinealon's stimulation of tryptophan hydroxylase — High-dose SSRI or MAOI antidepressants without medical supervision — potential additive serotonergic effects from Pinealon's stimulation of tryptophan hydroxylase
- Other serotonin-enhancing supplements — Other serotonin-enhancing supplements (5-HTP, St. John's Wort) at high doses — cumulative serotonergic stimulation
- Strong sedatives or CNS depressants — potential additive sedation from serotonergic modulation — Strong sedatives or CNS depressants — potential additive sedation from serotonergic modulation
Published research
What the studies show
Khavinson V, Linkova N, Kozhevnikova E, et al. · 2020
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Khavinson VKh, Lin'kova NS, Tarnovskaya SI, et al. · 2014
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Kraskovskaya NA, Kukanova EO, Lin'kova NS · 2017
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Silanteva IA, Komolkin AV, Morozova EA, et al. · 2019
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Mendzheritskiĭ AM, Karantysh GV, Ryzhak GA, et al. · 2014
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Khavinson et al. · 2021
Review summarizing a human cohort (n=72) with cerebral asthenia after cranial trauma given oral Pinealon 0.2 mg twice daily for 20-30 days, reporting improved cognitive and asthenic measures.
Head to head
Pinealon compared
Want the full picture?
The complete Pinealon research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.